Archibald Mixson, MD, Internal Medicine, Baltimore, MD, University of Maryland Medical Center

ArchibaldJMixsonMD

Internal Medicine Baltimore, MD

Endocrinology

Professor, Pathology, University of Maryland School of Medicine

Dr. Mixson is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mixson's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterPost-Doctoral Fellowship, Senior Staff Fellow, 1992 - 1995
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes and Metabolism, 1989 - 1992
  • National Cancer Institute
    National Cancer InstitutePost-Doctoral Fellowship, Metabolism, 1986 - 1989
  • Emory University
    Emory UniversityFellowship, 1980 - 1982
  • Emory University
    Emory UniversityInternship, Pediatrics, 1979 - 1980
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1979
  • Vanderbilt University
    Vanderbilt UniversityB.A, Math, Chemistry, 1970 - 1974

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1987 - 2021
  • GA State Medical License
    GA State Medical License 1983 - 1987
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Awarded 7 US and European Patents
  • Their lead product utilizes an HK peptide as a carrier of siRNA for improved wound healing Founder, Sirnaomics, Inc (Bethesda, MD/Suzhou, CH), 2007
  • Selected to Marquis Who’s Who in the World 2009
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • The uptake of pyrroline-5-carboxylate: group translocation mediating the transfer of reducing-oxidizing potential.  
    Mixson AJ and Phang JM, The Journal of Biological Chemistry
  • The proto-oncogenes of c-fos and c-jun modulate thyroid hormone inhibition of human thyrotropin beta subunit gene expression in opposite directions.  
    Bodenner DL, McClaskey JH, Kim MK, Mixson AJ, and Weintraub BD, Biochemical and Biophysical Research Communications
  • Thyrotropin-secreting pituitary carcinoma.  
    Mixson AJ. Friedman T, Katz DA, Feuerstein IM, Tauberger JK, Colandrea JM, Doppman JL, Oldfield EH, and Weintraub BD, Journal of Clinical Endocrinology and Metabolism
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • The uptake of pyrroline-5-carboxylate: group translocation mediating redox transfers.
    Mixson AJ and Phang JM, Federal Proceedings
  • Diverse phenotypes of 11 kindreds with generalized thyroid hormone resistance and novel mutations in the gene encoding the T3 beta receptor.
    Mixson AJ, Parrilla R, Usala SJ, Ransom SC, McClaskey JH, McPherson JA, and Weintraub B.D, Clinical Research
  • Language fluency associated with Thyroid Hormone Resistance.
    Mixson AJ, International Symposium on Thyroid Hormone Resistance, Cambridge, England
  • Join now to see all

Lectures

  • Liposomal Delivery Systems for Central and Peripheral Hyperalimentation solutions. 
    Cape Sunion Beach, Greece

Other

  • Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy. 
    US patent
  • Cationic vehicle: DNA complexes and their use in gene therapy. 
    #EPO819758B1
  • Branched Histidine copolymers and methods for using the same. 
    US Patent
  • Join now to see all

Grant Support

  • Ident. Of Structural Features Of HK Polyplexes For Imprv. Sirna Deliv. To TumorsNational Cancer Institute2009–2011
  • Gene Delivery Of P53 In A Tumor-Bearing Mouse ModelNational Cancer Institute2004–2007
  • Inhibition Of Intracerebral Gliomas With DnazymesNational Cancer Institute2004
  • Systemic Delivery Of P53 Inhibits Breast CancerNational Cancer Institute1997–2001

Hospital Affiliations